RALEIGH, N.C., Sept. 15, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that results of its KRN5500 study have been selected for presentation at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain to be held in San Francisco, November 19-21, 2009. Sharon M. Weinstein, MD, a leading investigator in the study, will present a poster entitled, "KRN5500 Demonstrates Significant Reduction in Neuropathic Pain Intensity in Patients with Cancer."
